feed,title,long_url,short_url
SeekingAlpha,AstraZeneca finalizes sale of Atacand rights for $400M,https://seekingalpha.com/news/3648218,
SeekingAlpha,Merck's Recent Acquisition Highlights OWS Funding Flowing Into COVID-19 Therapeutics,https://seekingalpha.com/article/4397128,
